anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

159,421-159,480 of 319,975

filter-aware
02
AstraZeneca | Results Presentation Deck | 40 slidesAstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
03
AstraZeneca | Results Presentation Deck | 40 slidesAstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
04
AstraZeneca | Results Presentation Deck | 40 slidesAstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
05
AstraZeneca | Results Presentation Deck | 40 slidesAstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
06
Includes footnotes explaining abbreviations and specific financial impacts.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Need1 hit
07
The slide uses a table to categorize pipeline progress into regulatory approval, submission, and Phase III data readouts.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Need1 hit
08
The slide uses a waterfall-style logic to decompose revenue growth sources.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Need1 hit
09
The slide uses two side-by-side tables to compare revenue, growth percentages, and ratios across different business segments.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Need1 hit
10
The slide uses a Venn-diagram-like visual to show the synergy between the two companies.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
11
AstraZeneca | Results Presentation Deck | 40 slidesAstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
12
The slide uses stacked bar charts to visualize revenue growth over time (Q1 2018 - Q1 2021) for two pharmaceutical products.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
13
Slide 13 of a conference presentation deck.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
14
Includes footnotes detailing specific medical indications and market regions.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
15
The slide uses stacked bar charts to show revenue composition over time (Q1 2018 - Q1 2021).AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
16
The chart shows revenue breakdown by product (Fasenra, Symbicort, Pulmicort, Other) from Q1 2018 to Q1 2021.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
17
Includes specific market share and revenue data for Fasenra, Breztri, Lokelma, and roxadustat.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
18
The slide uses a stacked bar chart to distinguish between China and EMs ex China revenue over time.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
19
AstraZeneca | Results Presentation Deck | 40 slidesAstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
20
Includes footnotes regarding exchange rates, CER, and specific expense definitions.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
21
The table includes a specific line item for the impact of the pandemic vaccine.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
22
Includes a trend line on the bar chart and a credit rating footnote.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
23
The slide uses a circular process diagram to link four strategic financial pillars.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
24
The slide includes a disclaimer at the bottom regarding the exclusion of COVID-19 vaccine impact and the Alexion acquisition.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
25
Includes specific financial targets ($500m synergies, double-digit growth/accretion).AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
26
AstraZeneca | Results Presentation Deck | 40 slidesAstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
27
The slide uses a three-column layout to categorize progress into clinical data, rollout, and antibody development.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
28
The slide uses a column-based layout to map specific drug candidates to disease areas.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
29
The slide uses a three-column layout to show the evolution from legacy product (Synagis) to clinical trial results (Phase IIb and Phase III) for nirsevimab.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Loop · Before After1 hit
30
The slide uses a split-layout to contrast early-stage development (left) with late-stage/marketed assets (right).AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
31
Memorial slide for a deceased executive.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
32
Slide 32 of a presentation, likely from AstraZeneca given the drug names.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
33
The slide uses a grid-based layout to map drug indications against patient segments and treatment lines.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
34
The slide uses a two-column layout to contrast early-stage pipeline assets with late-stage/marketed assets.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
35
The slide uses a matrix-style layout to organize pipeline events by time and event type.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Loop · Maturity Curve1 hit
36
AstraZeneca | Results Presentation Deck | 40 slidesAstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
37
The slide uses a three-column layout to summarize key business drivers.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations 1 hit
38
The slide uses a stylized human head graphic with digital circuitry patterns.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
39
The slide lists specific drug candidates, their targets, clinical phases, indications, and expected milestones as of April 2021.AstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
40
AstraZeneca | Results Presentation Deck | 40 slidesAstraZeneca | Results Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
01
Slide 1
Bausch Health Companies | Shareholder Engagement Presentation Deck | 18 slidesBausch Health Companies | Shareholder Engagement Presentation Deck | 18 slides · Bausch Health
Shareholder letter Investor relations 1 hit
02
Bausch Health Companies | Shareholder Engagement Presentation Deck | 18 slidesBausch Health Companies | Shareholder Engagement Presentation Deck | 18 slides · Bausch Health
Shareholder letter Investor relations 1 hit
03
Bausch Health Companies | Shareholder Engagement Presentation Deck | 18 slidesBausch Health Companies | Shareholder Engagement Presentation Deck | 18 slides · Bausch Health
Shareholder letter Investor relations 1 hit
04
Bausch Health Companies | Shareholder Engagement Presentation Deck | 18 slidesBausch Health Companies | Shareholder Engagement Presentation Deck | 18 slides · Bausch Health
Shareholder letter Investor relations 1 hit
05
Bausch Health Companies | Shareholder Engagement Presentation Deck | 18 slidesBausch Health Companies | Shareholder Engagement Presentation Deck | 18 slides · Bausch Health
Shareholder letter Investor relations Beat · Attention1 hit
06
Bausch Health Companies | Shareholder Engagement Presentation Deck | 18 slidesBausch Health Companies | Shareholder Engagement Presentation Deck | 18 slides · Bausch Health
Shareholder letter Investor relations 1 hit
07
Bausch Health Companies | Shareholder Engagement Presentation Deck | 18 slidesBausch Health Companies | Shareholder Engagement Presentation Deck | 18 slides · Bausch Health
Shareholder letter Investor relations 1 hit
08
The slide uses a split-screen layout to contrast past performance with future outlook.Bausch Health Companies | Shareholder Engagement Presentation Deck | 18 slides · Bausch Health
Shareholder letter Investor relations Beat · Need1 hit
09
The slide uses a three-row layout to categorize business activities, with logos and product names serving as visual evidence for the first two pillars.Bausch Health Companies | Shareholder Engagement Presentation Deck | 18 slides · Bausch Health
Shareholder letter Investor relations Beat · Satisfaction1 hit
10
Bausch Health Companies | Shareholder Engagement Presentation Deck | 18 slidesBausch Health Companies | Shareholder Engagement Presentation Deck | 18 slides · Bausch Health
Shareholder letter Investor relations 1 hit
11
The slide uses a timeline-like list of milestones on the left and a detailed results summary on the right.Bausch Health Companies | Shareholder Engagement Presentation Deck | 18 slides · Bausch Health
Shareholder letter Investor relations Beat · Visualization1 hit
12
Uses a process diagram to show how current operational improvements lead to three distinct strategic paths.Bausch Health Companies | Shareholder Engagement Presentation Deck | 18 slides · Bausch Health
Shareholder letter Investor relations Loop · Cost Of Inaction1 hit
13
Bausch Health Companies | Shareholder Engagement Presentation Deck | 18 slidesBausch Health Companies | Shareholder Engagement Presentation Deck | 18 slides · Bausch Health
Shareholder letter Investor relations 1 hit
14
Bausch Health Companies | Shareholder Engagement Presentation Deck | 18 slidesBausch Health Companies | Shareholder Engagement Presentation Deck | 18 slides · Bausch Health
Shareholder letter Investor relations Loop · Why Now1 hit
15
Bausch Health Companies | Shareholder Engagement Presentation Deck | 18 slidesBausch Health Companies | Shareholder Engagement Presentation Deck | 18 slides · Bausch Health
Shareholder letter Investor relations 1 hit
16
Bausch Health Companies | Shareholder Engagement Presentation Deck | 18 slidesBausch Health Companies | Shareholder Engagement Presentation Deck | 18 slides · Bausch Health
Shareholder letter Investor relations 1 hit
17
Includes specific definitions for exclusions: Restructuring and integration costs, Asset Impairments, Goodwill Impairments, and Share-based Compensation.Bausch Health Companies | Shareholder Engagement Presentation Deck | 18 slides · Bausch Health
Shareholder letter Investor relations 1 hit
18
Standard financial disclosure page for Bausch Health.Bausch Health Companies | Shareholder Engagement Presentation Deck | 18 slides · Bausch Health
Shareholder letter Investor relations 1 hit
01
Slide 1
BlackRock | Results Presentation Deck | 11 slidesBlackRock | Results Presentation Deck | 11 slides · BlackRock
Conference presentation Investor relations Beat · What Is1 hit
02
The slide uses stacked bar charts to compare AUM vs Revenue metrics for BlackRock as of Q1 2021.BlackRock | Results Presentation Deck | 11 slides · BlackRock
Conference presentation Investor relations Beat · What Is1 hit
03
Includes LTM organic asset growth rate and LTM organic base fee growth rate percentages above each bar.BlackRock | Results Presentation Deck | 11 slides · BlackRock
Conference presentation Investor relations Beat · What IsLoop · Mece Breakdown1 hit